Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Sheehan

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
The American Journal of Gastroenterology|April 5, 2017
The Impact of a Prior Diagnosis of Barrett's Esophagus on Esophageal Adenocarcinoma SurvivalAngela C Tramontano, Deirdre F Sheehan, Jennifer M Yeh, et al.
AIDS (London, England)|April 24, 2018
Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ cell count at least 500 cells/μlChung Yin Kong, Keith Sigel, Steven D Criss, et al.
Science (New York, N.Y.)|April 13, 2013
Persistent LCMV infection is controlled by blockade of type I interferon signalingJohn R Teijaro, Cherie Ng, Andrew M Lee, et al.
Immunity|October 24, 2007
Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipidsChristophe Paget, Thierry Mallevaey, Anneliese O Speak, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2013
Identifying the initiating events of anti-Listeria responses using mice with conditional loss of IFN-γ receptor subunit 1 (IFNGR1)Sang Hun Lee, Javier A Carrero, Ravindra Uppaluri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
New combination of the old drugs for elderly patients with small-cell lung cancer: a phase II study of the PAVE regimenV Westeel, N Murray, K Gelmon, et al.
Journal of Virology|October 18, 2019
Distinct Roles of Interferon Alpha and Beta in Controlling Chikungunya Virus Replication and Modulating Neutrophil-Mediated InflammationLindsey E Cook, Marissa C Locke, Alissa R Young, et al.
Plos One|October 25, 2013
Loss of DAP12 and FcRγ drives exaggerated IL-12 production and CD8(+) T cell response by CCR2(+) Mo-DCsGrzegorz B Gmyrek, Holly M Akilesh, Daniel B Graham, et al.
Nature Immunology|June 14, 2005
A critical function for type I interferons in cancer immunoeditingGavin P Dunn, Allen T Bruce, Kathleen C F Sheehan, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|November 23, 2006
Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfectionKathleen C F Sheehan, Koon Siew Lai, Gavin P Dunn, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
The American Journal of Gastroenterology|April 5, 2017
The Impact of a Prior Diagnosis of Barrett's Esophagus on Esophageal Adenocarcinoma SurvivalAngela C Tramontano, Deirdre F Sheehan, Jennifer M Yeh, et al.
AIDS (London, England)|April 24, 2018
Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ cell count at least 500 cells/μlChung Yin Kong, Keith Sigel, Steven D Criss, et al.
Science (New York, N.Y.)|April 13, 2013
Persistent LCMV infection is controlled by blockade of type I interferon signalingJohn R Teijaro, Cherie Ng, Andrew M Lee, et al.
Immunity|October 24, 2007
Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipidsChristophe Paget, Thierry Mallevaey, Anneliese O Speak, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2013
Identifying the initiating events of anti-Listeria responses using mice with conditional loss of IFN-γ receptor subunit 1 (IFNGR1)Sang Hun Lee, Javier A Carrero, Ravindra Uppaluri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
New combination of the old drugs for elderly patients with small-cell lung cancer: a phase II study of the PAVE regimenV Westeel, N Murray, K Gelmon, et al.
Journal of Virology|October 18, 2019
Distinct Roles of Interferon Alpha and Beta in Controlling Chikungunya Virus Replication and Modulating Neutrophil-Mediated InflammationLindsey E Cook, Marissa C Locke, Alissa R Young, et al.
Plos One|October 25, 2013
Loss of DAP12 and FcRγ drives exaggerated IL-12 production and CD8(+) T cell response by CCR2(+) Mo-DCsGrzegorz B Gmyrek, Holly M Akilesh, Daniel B Graham, et al.
Nature Immunology|June 14, 2005
A critical function for type I interferons in cancer immunoeditingGavin P Dunn, Allen T Bruce, Kathleen C F Sheehan, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|November 23, 2006
Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfectionKathleen C F Sheehan, Koon Siew Lai, Gavin P Dunn, et al.
Pageof 10